First AD

Second AD

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Updates in the Treatment of B-cell Lymphoma: Focus on Mantle Cell Lymphoma, Follicular Lymphoma, and Marginal Zone Lymphoma

Peer Exchange

Expert panelists discuss a number of recent updates in B-cell lymphoma, particularly mantle cell lymphoma, follicular lymphoma and marginal zone lymphoma, that were presented at key conferences in 2021. 

An Overview of Mantle Cell Lymphoma and Frontline Therapy

Considerations for Selection and Use of Frontline Therapy in Mantle Cell Lymphoma 

Second-Line Therapy for MCL: Differentiating Available BTK Inhibitors 

CAR T-cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma 

Optimizing MCL Management: Sequencing and Combination Strategies

Clinical Pearls in the Management of Mantle Cell Lymphoma

Pathophysiology of Follicular Lymphoma and Frontline Therapy

Novel Therapies and Treatment Selection in Patients With Relapsed/Refractory FL 

PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma 

Optimizing the Sequencing of Therapy in Follicular Lymphoma 

Clinical Pearls in the Management of Follicular Lymphoma 

Frontline Treatment Options for Marginal Zone Lymphoma 

Novel Treatment Strategies for Relapsed/Refractory MZL 

Clinical Pearls in the Management of Marginal Zone Lymphoma 